Cal-Os/Cal-Os Plus D/Cal-Os Chew Use In Pregnancy & Lactation

Cal-Os Plus D: Pregnancy: Calcium crosses the placenta. The amount of calcium reaching the fetus is determined by maternal physiological changes. Calcium requirements are the same in pregnant and nonpregnant females. Fetal harm is not expected if maternal calcium concentrations are monitored and maintained. Vitamin D crosses the placenta but the transfer to the fetus from the mother is low. Maternal supplementation has not been shown to affect pregnancy outcomes. Vitamin D requirements are the same in pregnant and nonpregnant females. The daily intake should not exceed 1,500 mg of calcium and 600 IU of Vitamin D in pregnancy.
Lactation: Calcium is excreted in breast milk. The amount of calcium in breast milk is not altered by maternal calcium intake. Calcium requirements are the same in lactating and nonlactating females. Maternal vitamin D requirements are the same for breast-feeding and non-breast feeding women. However, the amount of vitamin D in breast milk does not correlate with serum concentrations in the infant. This drug poses minimal risk to the infant when used during breastfeeding.
Cal-Os Chew: The dietary reference intakes for calcium carbonate chewable tablets in pregnant or lactating females are the same as in nonpregnant or nonlactating females.